Cambridge Healthtech’s 14th Annual
Coverage and Reimbursement for Diagnostic Innovation
Payers, Innovators, and Policymakers Shaping Coverage Strategies Together
August 24-25, 2026
Coverage and reimbursement for diagnostic innovation are more complex than ever, with legislative shifts, evolving coding frameworks, and the rise of AI-based diagnostics creating new challenges and opportunities for innovators and payers alike. Cambridge Healthtech Institute’s 14th annual conference on Coverage and Reimbursement for Diagnostic Innovation provides a forum for industry leaders, payers, and policymakers to exchange perspectives on the pressing issues shaping market access today. Participants will engage in discussions on legislative trends, prior authorization challenges, and coding and rate-setting complexities in a time when diagnostics are evolving rapidly. This program offers a unique opportunity to share commercialization strategies and peer-to-peer insights that can help diagnostic innovators navigate a changing coverage landscape.
Coverage will include, but is not limited to:
- Legislative updates impacting diagnostics
- Coding and rate-setting challenges for novel assays
- Coverage strategies for AI-based diagnostics
- Prior authorization and payer engagement
- Reimbursement for complex diagnostics, including MRD
- Early-market strategies and access planning
The deadline for priority consideration is February 2, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: